Among 37 million diabetic Americans, 25% of them have a painful disease, diabetic neuropathy, which results in nerve loss and usually affects the hands and feet, and can cause discomfort and numbness.

This study included 216 participants with painful diabetic neuropathy symptoms unresponsive to treatment for at least a year. 

After six months, the participants reported an average pain reduction of 76%, compared to a 2% rise in discomfort for those who did not. 

Two years later, participants reported 80% improvement in their motor skills, sensitivity, and reflexes, and 66% still exhibited progress. Eight people who suffered illnesses by their devices experienced three recoveries, while the other five required device removal owing to infection. Also, participants reported an 80% improvement in their average level of discomfort, and 66% said that their motor function, sensitivity, and reflexes had improved. With acceptable safety, high-frequency stimulation reduces pain more effectively than low-frequency stimulation.

3% of people had their implants removed due to infection, but none had the gadgets removed due to the devices effectiveness. Additionally, the results show that high-frequency stimulation appears to be more effective at reducing pain than low-frequency stimulation.

This study reveals that high-frequency stimulation offers dependable long-term pain alleviation. Further improvements in motor function, sensation, and reflexes show that this therapy may have disease-modifying potential. More studies were required to confirm the understanding of this spinal cord stimulation therapy for treating diabetic neuropathy.

(Source: https://www.hindustantimes.com/lifestyle/health/diabetic-neuropathy-patients-can-benefit-from-spinal-cord-stimulation-study-101678097408374.html)